{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:45Z","timestamp":1792788165532,"version":"4.5.0"},"reference-count":0,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["No.2023JJ41019"],"award-info":[{"award-number":["No.2023JJ41019"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Fund of the National Clinical Research","award":["No.2023LNJJ02"],"award-info":[{"award-number":["No.2023LNJJ02"]}],"id":[{"id":"https:\/\/ror.org\/03ddkvp86","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05327-4","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:43:58Z","timestamp":1791254638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Young bone marrow mesenchymal stem cell-derived exosomes promote perfusion recovery and tissue repair via the miR-455-5p\/Bach1 axis after hindlimb ischemia"],"prefix":"10.1186","author":[{"given":"Xuelun","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongmei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1671-6601","authenticated-orcid":false,"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05327-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:43:59Z","timestamp":1791254639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05327-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":0,"alternative-id":["5327"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05327-4","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were reviewed and approved by the Animal Ethics Committee of Xiangya Hospital, Central South University. The original animal protocol was approved on November 10, 2022 (Approval No. 2022111061; approved project title: \u201cMechanism of miR-140-5p in Improving Age-Related Decline in Angiogenesis via Regulation of Bach1\u201d). During the course of the study, exosomal miRNA sequencing, target prediction, and candidate-miRNA screening identified miR-455-5p as a candidate for further investigation. A formal protocol amendment covering the miR-455-5p-related animal experiments was approved on December 22, 2023 (Approval No. 202312150; approved project title, translated from Chinese: \u201cMechanistic Study of miR-455-5p in Ameliorating Aging-Related Decline in Angiogenic Capacity Through Regulation of Bach1\u201d). All experimental procedures were conducted in accordance with the institutional guidelines for the care and use of laboratory animals. HUVECs were purchased from the China Center for Type Culture Collection (Wuhan, China). The human umbilical cord tissue used for the original isolation of these cells was collected with prior approval from the relevant ethics committee and that written informed consent was obtained from the donors before tissue collection. The authors did not directly recruit human participants or collect new human biological specimens or identifiable human data in this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}